What Are Fat Dissolving Injections
Fat dissolving injections are injectable formulations designed to reduce localized fat deposits without surgery. The most common active ingredient is deoxycholic acid, a bile acid that helps break down dietary fat. In the United States, the FDA approved a deoxycholic acid injectable under the brand name Kybella in 2015 for submental fat, commonly referred to as a double chin. Other products, such as Aqualyx, contain deoxycholic acid or similar compounds and are available in many countries outside the U.S. These injections target small, stubborn fat pockets, typically in the chin, jawline, abdomen, and thighs, and are not intended as a weight-loss treatment.
Treatment involves a series of sessions, usually spaced several weeks apart, with each session involving multiple injections into the target area. Results are gradual and depend on the specific formulation, dosage, and number of sessions. Companies such as Kythera Biopharmaceuticals developed the first FDA-approved deoxycholic acid product, and subsequent generic versions have entered the market. The global injectable cosmetic market, which includes fat dissolving products, continues to grow, driven by demand for minimally invasive body contouring options.
Common and Documented Side Effects
Common side effects of fat dissolving injections include swelling, bruising, pain, redness, and numbness at the injection site. These reactions are typically mild and resolve within days to weeks. Some patients report firm lumps or hardness under the skin, which can persist for months as the body processes the destroyed fat cells. Clinical trial data for Kybella showed that nearly all treated patients experienced some degree of swelling, and a significant percentage reported bruising and pain.
Less common but documented side effects include nerve injury, which can cause temporary or prolonged muscle weakness, particularly in the jaw and mouth area. Skin ulceration, tissue necrosis, and uneven contour or dimpling have also been reported, especially when injections are administered improperly or in excessive amounts. In rare cases, patients may experience allergic reactions, infection, or seroma formation, where fluid collects under the skin. These risks are higher when the procedure is performed by unqualified providers or using unregulated products.
Safety Considerations and Regulatory Oversight
Regulatory status varies by country and product. The FDA has approved only deoxycholic acid injectables for submental fat, and many other fat dissolving formulations remain unapproved or are marketed under different regulatory categories. In the European Union and other regions, products like Aqualyx carry CE marking, indicating conformity with health and safety standards, but they are not universally recognized as equivalent to FDA approval. The FDA maintains a database of adverse event reports, and healthcare professionals and patients can submit serious side effects through the MedWatch system.
Choosing a qualified, licensed medical professional is critical to minimizing risks. Board-certified dermatologists, plastic surgeons, and licensed injectors with specific training in fat dissolving procedures are recommended. Patients should verify product authenticity, confirm the provider's credentials, and review before-and-after photos of actual cases. The American Society of Plastic Surgeons and the Aesthetic Surgery Journal publish guidelines and safety data on injectable fat reduction treatments. For current regulatory and safety information, the FDA website provides official updates on approved products and reported adverse events, and the European Medicines Agency offers corresponding oversight for products marketed in the EU.